Preparation and characterization of celecoxib dispersions in soluplus®: Comparison of spray drying and conventional methods

Iranian Journal of Pharmaceutical Research

Volumn 14, Issue 1, 2015, Pages 35-50

  Homayouni, Alireza ^a   Sadeghi, Fatemeh ^a,b   Nokhodchi, Ali ^c,d   Varshosaz, Jaleh ^e   Garekani, Hadi Afrasiabi ^a,f  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF KENT   (United Kingdom)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Celecoxib; Dissolution rate; Solid dispersion; Solid states; Soluplus

Indexed keywords

CELECOXIB; COPOLYMER; POLYVINYL CAPROLACTAME POLYVINYL ACETATE POLYETHYLENE GLYCOL GRAFT COPOLYMER; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STABILITY; EVAPORATION; INFRARED SPECTROSCOPY; LIPOPHILICITY; MELTING POINT; MORPHOLOGY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TEMPERATURE; X RAY POWDER DIFFRACTION;

EID: 84911475335     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Merisko-Liversidge E, Liversidge GG and Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. (2003) 18: 113-120.
2. Chen H, Khemtong C, Yang X and Chang X and Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discov. Today(2011) 16: 354-360.
3. Leuner C and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. (2000) 50: 47-60.
4. Baird JA and Taylor LS. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv. Drug Deliv. Rev. (2012) 64: 396-421.
5. Vasconcelos Tf, Sarmento B and Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today(2007) 12: 1068-1075.
6. Khodaverdi E, Khalili N, Zangiabadi F and Homayouni A. Preparation, characterization and stability studies of glassy solid dispersions of indomethacin using PVP and isomalt as carriers. Iran. J. Basic. Med. Sci. (2012) 15: 820-832.
7. Javadzadeh Y, Jafari-Navimipour B and Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int. J. Pharm. (2007) 341: 26-34.
8. Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR and Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharm. Sci. (2005) 8: 18-25.
9. Serajuddin ATM. Salt formation to improve drug solubility.Adv. Drug Deliv. Rev. (2007) 59: 603-616.
10. Alam MA, Ali R, Al-Jenoobi FI and Al-Mohizea AM. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates. Expert. Opin. Drug Deliv. (2012) 9: 1419-1440.
11. Hardung H, Djuric D and Ali S. Combining HME & solubilization: Soluplus - The solid solution. Drug Deliv. Tech. (2010) 10: 20-27.
12. Nagy ZK, Balogh A, Vajna B, Farkas A, Patyi G, Kramarics A and Marosi G. Comparison of electrospun and extruded Soluplus -based solid dosage forms of improved dissolution. J. Pharm. Sci. (2012) 101: 322-332.
13. Linn M, Collnot E-M, Djuric D, Hempel K, Fabian E, Kolter K and Lehr CM. Soluplus as an effective absorption enhancer of poorly soluble drugs in-vitro and in-vivo. Eur. J. Pharm. Sci. (2012) 45: 336-343.
14. Maniruzzaman M, Rana MM, Boateng JS, Mitchell JC and Douroumis D. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers. Drug Dev. Ind. Pharm. (2013) 39: 218-227.
15. Pokharkar VB, Malhi T and Mandpe L. Bicalutamide nanocrystals with improved oral bioavailability: in vitro and in vivo evaluation. Pharm. Dev. Tech. (2013) 18: 660-666.
16. Saha RN, Sajeev C, Jadhav PR, Patil SP and Srinivasan N. Determination of celecoxib in pharmaceutical formulations using UV spectrophotometry and liquid chromatography. J. Pharm. Biomed. Anal. (2002) 28: 741-751.
17. Wang S, Liu Y, Sun C, Hao Y, Jiang T and Zheng L. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J. Pharm. Pharm. Sci. (2010) 13: 589-606.
18. Lindenberg M, Kopp S and Dressman JB. Classifcation of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classifcation system. Eur. J. Pharm. Biopharm. (2004) 58: 265-278.
19. Dolenc A, Kristl J, Baumgartner S and Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int. J. Pharm. (2009) 376: 204-212.
20. Shono Y, Jantratid E, Janssen N, Kesisoglou F, Mao Y, Vertzoni M, Reppas C and Dressman J. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling. Europ. J. Pharm. Biopharm. (2009) 73: 107-114.
21. Fouad EA, El-Badry M, Mahrous GM, Alanazi FK, Neau SH and Alsarra IA. The use of spray-drying to enhance celecoxib solubility. Drug Dev. Ind. Pharm. (2011) 37: 1463-1472.
22. Andrews GP, Abu-Diak O, Kusmanto F, Hornsby P, Hui Z and Jones DS. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J. Pharm. Pharmacol. (2010) 62: 1580-1590.
23. Gupta P, Kakumanu VK and Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. (2004) 21: 1762-1769.
24. Rawat S and Jain SK. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes. Eur. J. Pharm. Biopharm. (2004) 57: 263-267.
25. Paradkar A, Maheshwari M, Kamble R, Grimsey I and York P. Design and evaluation of celecoxib porous particles using melt sonocrystallization. Pharm. Res. (2006) 23: 1395-1400.
26. Homar M, Ubrich N, Ghazouani FE, Kristl J, Kerč J and Maincent P. Infuence of polymers on the bioavailability of microencapsulated celecoxib. J. Microencapsul. (2007) 24: 621-633.
27. Garti N, Avrahami M and Aserin A. Improved solubilization of Celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution. J. Collod Interf. Sci. (2006) 299: 352-365.
28. Costa P and Sousa Lobo JM. Modeling and comparison of dissolution profles. Eur. J. Pharm. Sci. (2001) 13: 123-133.
29. Seedher N and Bhatia S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS Pharm. Sci. Tech. (2003) 4: 1-9.
30. Janssens S and Van Den Mooter G. Review: Physical chemistry of solid dispersions. J. Pharm. Pharmacol. (2009) 61: 1571-1586.
31. Paudel A, Worku ZA, Meeus J, Guns S and Vanden Mooter G. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: Formulation and process considerations. Int. J. Pharm. (2013) 453: 253-84.
32. Chawla G, Gupta P, Thilagavathi R, Chakraborti AK and Bansal AK. Characterization of solid-state forms of celecoxib. Eur. J. Pharm. Sci. (2003) 20: 305-317.
33. Terife G, Wang P, Faridi N and Gogos CG. Hot melt mixing and foaming of soluplus and indomethacin. J. Polym. Eng. Sci. (2012) 52: 1629-1639.
34. Gupta P, Thilagavathi R, Chakraborti AK and Bansal AK. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Mol. Pharm. (2005) 2: 384-391.
35. Puri V, Dantuluri AK, Kumar M, Karar N and Bansal AK. Wettability and surface chemistry of crystalline and amorphous forms of a poorly water soluble drug. Eur. J. pharm. Sci. (2010) 40: 84-93.
36. Meulenaar J, Beijnen JH, Schellens JH and Nuijen B. Slow dissolution behaviour of amorphous capecitabine. Int J. Pharm. (2013) 441: 213-217.
37. Langham ZA, Booth J, Hughes LP, Reynolds GK and Wren SAC. Mechanistic insights into the dissolution of spray-dried amorphous solid dispersions. J. Pharm. Sci. (2012) 101: 2798-2810.
38. van Drooge DJ, Hinrichs WL and Frijlink HW. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J. Control. Release(2004) 97: 441-452.
39. Bolourchian N, Mahboobian MM and Dadashzadeh S. The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iran. J. Pharm. Res. (2013) 12: 11-20.
40. Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur. J. Pharm. Biopharm. (2002) 54: 107-117.
41. Lee J, Kim M, Yoon H, Shim C, Ko H, Cho S, Lee D and Khang G. Enhanced dissolution rate of celecoxib using PVP and/or HPMC-based solid dispersions prepared by spray drying method. J. Pharm. Invest. (2013) 43: 205-213.
42. Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. (2002) 231: 131-144.